AU8510398A - Fibrinogen receptor antagonists - Google Patents

Fibrinogen receptor antagonists

Info

Publication number: AU8510398A
Authority: AU; Australia
Prior art keywords: receptor antagonists; fibrinogen receptor; fibrinogen; antagonists; receptor
Prior art date: 1997-07-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU85103/98A

Inventor

Dirk Heerding

James M. Samanen

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

SmithKline Beecham Corp

Original Assignee

SmithKline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-25

Filing date

1998-07-23

Publication date

1999-02-16

1998-07-23 Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp

1999-02-16 Publication of AU8510398A publication Critical patent/AU8510398A/en

Status Abandoned legal-status Critical Current

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Health & Medical Sciences (AREA)
Diabetes (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Hydrogenated Pyridines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU85103/98A 1997-07-25 1998-07-23 Fibrinogen receptor antagonists Abandoned AU8510398A (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US5378897P	1997-07-25	1997-07-25
US60053788		1997-07-25
US6354597P	1997-10-28	1997-10-28
US60063545		1997-10-28
PCT/US1998/015288 WO1999004796A1 (en)	1997-07-25	1998-07-23	Fibrinogen receptor antagonists

Publications (1)

Publication Number	Publication Date
AU8510398A true AU8510398A (en)	1999-02-16

Family

ID=26732245

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU85103/98A Abandoned AU8510398A (en)	1997-07-25	1998-07-23	Fibrinogen receptor antagonists

Country Status (6)

Country	Link
EP (1)	EP1001777A4 (en)
JP (1)	JP2002509547A (en)
AU (1)	AU8510398A (en)
CA (1)	CA2297909A1 (en)
CO (1)	CO4970784A1 (en)
WO (1)	WO1999004796A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6069143A (en) *	1994-12-20	2000-05-30	Smithkline Beecham Corporation	Fibrinogen receptor antagonists

1998
- 1998-07-23 EP EP98935967A patent/EP1001777A4/en not_active Withdrawn
- 1998-07-23 CA CA002297909A patent/CA2297909A1/en not_active Abandoned
- 1998-07-23 AU AU85103/98A patent/AU8510398A/en not_active Abandoned
- 1998-07-23 WO PCT/US1998/015288 patent/WO1999004796A1/en not_active Application Discontinuation
- 1998-07-23 JP JP51008299A patent/JP2002509547A/en active Pending
- 1998-07-24 CO CO98042201A patent/CO4970784A1/en unknown

Also Published As

Publication number	Publication date
JP2002509547A (en)	2002-03-26
EP1001777A4 (en)	2002-10-09
CO4970784A1 (en)	2000-11-07
CA2297909A1 (en)	1999-02-04
EP1001777A1 (en)	2000-05-24
WO1999004796A1 (en)	1999-02-04

Similar Documents

Publication	Publication Date	Title
AU3579897A (en)	1998-01-21	Fibrinogen receptor antagonists
AU1441695A (en)	1995-07-10	Fibrinogen receptor antagonists
EP0810994A4 (en)	1998-05-06	Fibrinogen receptor antagonists
AU7692996A (en)	1997-06-27	Receptor antagonists
AU4746297A (en)	1998-04-24	Vitronectin receptor antagonists
AU8689798A (en)	1999-02-22	Integrin receptor antagonists
AU2143295A (en)	1995-10-17	Neurokinin receptor antagonists
EP0866705A4 (en)	1999-03-03	Fibrinogen receptor antagonists
EP0885205A4 (en)	2002-11-27	Fibrinogen receptor antagonists
AU3503797A (en)	1998-01-21	Fibrinogen receptor antagonist prodrugs
AU2242197A (en)	1997-08-01	Benzimidzolyl neuropeptide y receptor antagonists
EP0885213A4 (en)	1999-04-28	Fibrinogen receptor antagonists
AU8673198A (en)	1999-02-22	Il-8 receptor antagonists
EP0796098A4 (en)	1998-04-29	Fibrinogen receptor antagonists
HK1031726A1 (en)	2001-06-22	Thrombin receptor antagonists
AU1230795A (en)	1995-08-31	Adhesion receptor antagonists
EP0801650A4 (en)	1998-05-06	Fibrinogen receptor antagonists
AU9185598A (en)	1999-04-12	Novel neuropeptide y receptor antagonists
AU1296899A (en)	1999-05-31	Phenyl-alkyl-imidazoles as h3 receptor antagonists
EP0794779A4 (en)	1998-04-29	Fibrinogen receptor antagonists
AU5764298A (en)	1998-08-07	Tachykinin antagonists
AU6435098A (en)	1998-08-26	Il-8 receptor antagonists
AU1735200A (en)	2000-06-05	Novel isoxazoline fibrinogen receptor antagonists
AU3503397A (en)	1998-01-21	Fibrinogen receptor antagonist prodrugs
GB9515852D0 (en)	1995-10-04	Fibrinogen receptor antagonists

Legal Events

Date	Code	Title	Description
2000-04-13	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase